# | Title | Journal | Year | Citations |
---|
1 | 2019 European League Against Rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus | Annals of the Rheumatic Diseases | 2019 | 759 |
2 | Factors associated with damage accrual in patients with systemic lupus erythematosus: results from the Systemic Lupus International Collaborating Clinics (SLICC) Inception Cohort | Annals of the Rheumatic Diseases | 2015 | 391 |
3 | The frequency and outcome of lupus nephritis: results from an international inception cohort study | Rheumatology | 2016 | 370 |
4 | The role of viscosupplementation with hylan G-F 20 (Synvisc®) in the treatment of osteoarthritis of the knee: a Canadian multicenter trial comparing hylan G-F 20 alone, hylan G-F 20 with non-steroidal anti-inflammatory drugs (NSAIDs) and NSAIDs alone | Osteoarthritis and Cartilage | 1995 | 337 |
5 | Global epidemiology of systemic lupus erythematosus | Nature Reviews Rheumatology | 2021 | 229 |
6 | Applying Dynamic Simulation Modeling Methods in Health Care Delivery Research—The SIMULATE Checklist: Report of the ISPOR Simulation Modeling Emerging Good Practices Task Force | Value in Health | 2015 | 152 |
7 | Lymphoma risk in systemic lupus: effects of disease activity versus treatment | Annals of the Rheumatic Diseases | 2014 | 115 |
8 | Accidental exposures to peanut in a large cohort of Canadian children with peanut allergy | Clinical and Translational Allergy | 2015 | 91 |
9 | Gender and ethnic origin have no effect on longterm outcome of childhood-onset systemic lupus erythematosus | Journal of Rheumatology | 2004 | 80 |
10 | Increasing visits for anaphylaxis and the benefits of early epinephrine administration: A 4-year study at a pediatric emergency department in Montreal, Canada | Journal of Allergy and Clinical Immunology | 2016 | 77 |
11 | Temporal trends in prevalence of food allergy in Canada | Journal of Allergy and Clinical Immunology: in Practice | 2020 | 77 |
12 | Evaluation of Prehospital Management in a Canadian Emergency Department Anaphylaxis Cohort | Journal of Allergy and Clinical Immunology: in Practice | 2019 | 76 |
13 | Stand Up and Be Counted: Measuring and Mapping the Rheumatology Workforce in Canada | Journal of Rheumatology | 2017 | 72 |
14 | Gout, Hyperuricaemia and Crystal-Associated Disease Network (G-CAN) consensus statement regarding labels and definitions of disease states of gout | Annals of the Rheumatic Diseases | 2019 | 72 |
15 | Tryptase levels in children presenting with anaphylaxis: Temporal trends and associated factors | Journal of Allergy and Clinical Immunology | 2016 | 71 |
16 | Clinical Orofacial Examination in Juvenile Idiopathic Arthritis: International Consensus-based Recommendations for Monitoring Patients in Clinical Practice and Research Studies | Journal of Rheumatology | 2017 | 69 |
17 | CanVasc Recommendations for the Management of Antineutrophil Cytoplasm Antibody-associated Vasculitides | Journal of Rheumatology | 2016 | 66 |
18 | Review article: dermatological complications of immunosuppressive and anti-TNF therapy in inflammatory bowel disease | Alimentary Pharmacology and Therapeutics | 2013 | 63 |
19 | Nailfold capillary density is importantly associated over time with muscle and skin disease activity in juvenile dermatomyositis | Rheumatology | 2011 | 61 |
20 | DNA-damaging autoantibodies and cancer: the lupus butterfly theory | Nature Reviews Rheumatology | 2016 | 60 |
21 | Genome-wide association study and meta-analysis in multiple populations identifies new loci for peanut allergy and establishes C11orf30/EMSY as a genetic risk factor for food allergy | Journal of Allergy and Clinical Immunology | 2018 | 57 |
22 | Effect of Tumor Necrosis Factor Alpha Inhibition on Bone Density and Turnover Markers in Patients with Rheumatoid Arthritis and Spondyloarthropathy | Seminars in Arthritis and Rheumatism | 2009 | 52 |
23 | Sesame allergy: current perspectives | Journal of Asthma and Allergy | 2017 | 52 |
24 | Cardiovascular events prior to or early after diagnosis of systemic lupus erythematosus in the systemic lupus international collaborating clinics cohort | Lupus Science and Medicine | 2016 | 50 |
25 | A review on SLE and malignancy | Best Practice and Research in Clinical Rheumatology | 2017 | 50 |
26 | Immune-related Adverse Events Associated with Cancer Immunotherapy: A Review for the Practicing Rheumatologist | Journal of Rheumatology | 2020 | 47 |
27 | Systemic lupus erythematosus and risk of infection | Expert Review of Clinical Immunology | 2020 | 44 |
28 | Canadian Rheumatology Association Recommendations for the Assessment and Monitoring of Systemic Lupus Erythematosus | Journal of Rheumatology | 2018 | 43 |
29 | Evaluation of a Rheumatology Transition Clinic | Pediatric Rheumatology | 2015 | 41 |
30 | Adverse Events in Oral Immunotherapy for the Desensitization of Cow's Milk Allergy in Children: A Randomized Controlled Trial | Journal of Allergy and Clinical Immunology: in Practice | 2019 | 41 |
31 | A targeted association study in systemic lupus erythematosus identifies multiple susceptibility alleles | Genes and Immunity | 2011 | 40 |
32 | The 2021 EULAR/American College of Rheumatology points to consider for diagnosis, management and monitoring of the interleukin-1 mediated autoinflammatory diseases: cryopyrin-associated periodic syndromes, tumour necrosis factor receptor-associated periodic syndrome, mevalonate kinase deficiency, and deficiency of the interleukin-1 receptor antagonist | Annals of the Rheumatic Diseases | 2022 | 38 |
33 | Development of key performance indicators to evaluate centralized intake for patients with osteoarthritis and rheumatoid arthritis | Arthritis Research and Therapy | 2015 | 37 |
34 | European League Against Rheumatism (EULAR)/American College of Rheumatology (ACR) SLE classification criteria item performance | Annals of the Rheumatic Diseases | 2021 | 37 |
35 | Central nervous system vasculitis in adults and children | Handbook of Clinical Neurology / Edited By P J Vinken and G W Bruyn | 2016 | 35 |
36 | The Risk of Recurrent Anaphylaxis | Journal of Pediatrics | 2017 | 35 |
37 | Preexisting autoimmune disease and immune-related adverse events associated with anti-PD-1 cancer immunotherapy: a national case series from the Canadian Research Group of Rheumatology in Immuno-Oncology | Cancer Immunology, Immunotherapy | 2021 | 31 |
38 | Impact of glucocorticoids on the incidence of lupus-related major organ damage: a systematic literature review and meta-regression analysis of longitudinal observational studies | Lupus Science and Medicine | 2021 | 31 |
39 | Hydroxychloroquine prescription trends and predictors for excess dosing per recent ophthalmology guidelines | Arthritis Research and Therapy | 2018 | 30 |
40 | Smoking Is the Most Significant Modifiable Lung Cancer Risk Factor in Systemic Lupus Erythematosus | Journal of Rheumatology | 2018 | 27 |
41 | CanVasc Consensus Recommendations for the Management of Antineutrophil Cytoplasm Antibody-associated Vasculitis: 2020 Update | Journal of Rheumatology | 2021 | 27 |
42 | Systemic Lupus Erythematosus and Malignancies | Rheumatic Disease Clinics of North America | 2014 | 25 |
43 | Anaphylaxis across two Canadian pediatric centers: evaluating management disparities | Journal of Asthma and Allergy | 2017 | 25 |
44 | Disparities in rate, triggers, and management in pediatric and adult cases of suspected drug‐induced anaphylaxis in Canada | Immunity, Inflammation and Disease | 2018 | 25 |
45 | Non-biologic disease-modifying antirheumatic drugs (DMARDs) improve pain in inflammatory arthritis (IA): a systematic literature review of randomized controlled trials | Rheumatology International | 2013 | 23 |
46 | Risk of malignancy in patients with systemic lupus erythematosus: Systematic review and meta-analysis | Seminars in Arthritis and Rheumatism | 2021 | 23 |
47 | The economic burden of systemic lupus erythematosus in commercially- and medicaid-insured populations in the United States | Seminars in Arthritis and Rheumatism | 2020 | 22 |
48 | Cancer and Systemic Lupus Erythematosus | Rheumatic Disease Clinics of North America | 2020 | 22 |
49 | Gaps in Addressing Cardiovascular Risk in Rheumatoid Arthritis: Assessing Performance Using Cardiovascular Quality Indicators | Journal of Rheumatology | 2016 | 21 |
50 | Breast cancer in systemic lupus | Lupus | 2017 | 21 |